AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-20079423_ITM" title="Facts and information about INTAS PHARMA: ICICI SEEKS EXIT ROUTE (will sell its 12.5% stake in Intas Pharmaceutical as it is obliged to pay back its investors).">INTAS PHARMA: ICICI SEEKS EXIT ROUTE (will sell its 12.5% stake in Intas Pharmaceutical as it is obliged to pay back its investors).</a>
Close
Set up an RSS feed that alerts you when new articles from Asia Africa Intelligence Wire are available.
Frequently asked questions about RSS feeds
INTAS PHARMA: ICICI SEEKS EXIT ROUTE (will sell its 12.5% stake in Intas Pharmaceutical as it is obliged to pay back its investors).
(From India Business Insight)
ICICI Venture (IV) has decided to divest its 12.5 percent stake in Intas Pharma (IP), which it had acquired in 1996. The fund through which IV had financed the acquisition of stake in IP is coming to an end and IV is obliged to pay back its investors. IV, however, has decided not to go for an initial public offer.
...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- New painkiller from Intas Pharma.
- News wire article from: Asia Africa Intelligence Wire October 9, 2003 700+ words
...based Intas Pharmaceuticals Ltd (Intas Pharma) has developed a new molecule aceclofenac...to its turnover in the first year. Intas Pharma hopes that the new product will help...Rup 2.2 bn recorded in 2002-2003. Intas Pharma aims at achieving turnover of Rup 2...
- Intas Pharma lines up bio-pharma entry.
- News wire article from: Asia Africa Intelligence Wire October 21, 2003 700+ words
...Week) The Ahmedabad-based Intas Pharmaceuticals Ltd (Intas Pharma) has decided to foray into the biopharmaceuticals market...and kidney failure, the drug is in pre-clinical phase. Intas Pharma is also developing interferon alpha used in anticancer and...
- ICICI VENTURE TO SELL 12.5% STAKE IN INTAS PHARMA (book value of each share has...
- News wire article from: Asia Africa Intelligence Wire December 11, 2003 700+ words
...Ventures has decided to sell its 12.5 percent stake in Intas Pharma, Ahmedabad. Enam Financial Consultants has been appointed...earnings per share (EPS) has increased from Rs19 to Rs43. Intas Pharma manufactures and markets healthcare and pharmaceutical products...
- ICICI Ventures postpones Intas Pharma stake sale.
- News wire article from: Asia Africa Intelligence Wire April 5, 2004 700+ words
...Pharmaceuticals, has put the plan on the backburner, sensing it could fetch a higher valuation if the sale is delayed. Intas Pharma sources told ET that ICICI Ventures has conveyed its decision to the company. ICICI Ventures, however, was unavailable...
- NEW PHARMACEUTICAL PRODUCTS: M/S INTAS PHARMA LTD LAUNCHES GFLOTAS-D (product...
- News wire article from: Asia Africa Intelligence Wire January 31, 2005 700+ words
(From India Business Insight) M/s Intas Pharma Ltd has introduced Gflotas-D, a topical formulation containing a potent corticosteroid and a broad-spectrum antibacterial...
- ChrysCap to buy 12 percent in Intas Pharma.(Company Profile)
- Newspaper article from: Economic Times (New Delhi, India) December 13, 2005 700+ words
...47 percent of its existing paid-up capital. The purchase is being done at the rate of a little over Rs 912 per share. Intas Pharma is a leading player in the high growth theurapeutic areas of neurology, psychiatry, cardiology, diabetology, gastroenterology...
- GUJARAT ALL GEARED UP TO TAKE THE LEAD IN BIOTECH SECTOR (Zydus Cadila,...
- Magazine article from: India Business Insight January 11, 2007 700+ words
...However, Gujarat is likely to overtake Bangalore because leading pharmaceutical companies like Zydus Cadila, Alembic, Intas Pharma and Ambalal Sarabhai, which are in Gujarat, are focusing on this segment. Besides, there is an emergence of standalone...
- SYMBIOSIS IN BIOTECH (Aditya Birla Group to make strategic investments in the...
- News wire article from: Asia Africa Intelligence Wire August 1, 2005 700+ words
...The Aditya Birla Group proposes to make strategic investments in Indus Biotherapeutics, the biotechnology division of Intas Pharma. Indus began with high-value low-volume products and is currently in need of funds to build large bioreactors by 2007...
- INTAS PHARMA TO LAUNCH SERIES OF BIOTECH DRUGS (to largely focus on the...
- News wire article from: Asia Africa Intelligence Wire August 2, 2004 700+ words
(From India Business Insight) Intas Pharmaceuticals has put in four years of work in biotech development with investments of Rs40-45 crore and is now in a position to launch a series of new products at six-month intervals. The company has launched its first biotech product, Neukine (Human
- Intas Pharma to launch series of biotech drugs.
- News wire article from: Asia Africa Intelligence Wire August 2, 2004 700+ words
(From Business Line) Chennai, Aug 1 - FOUR years of biotech developmental work has put Intas Pharmaceuticals in a position to launch new products at six-month intervals, according to its officials. Intas' officials were in the city to promote the company's first biotech product, Neukine (Human